Corrigendum to 'Chemotherapy response score (CRS) as a surrogate marker for homologous recombination deficiency (HRD) based on loss of heterozygosity (LOH) in high grade serous ovarian cancer (HGSOC) (165)' [Gynecologic Oncology Volume 166, Supplement 1, August 2022, Page S98]

Autor: Silvana Wijaya, Jerold Loh, Diana Lim, Soon Boon Justin Wong, Jeffrey Low, Joseph Ng, Pearl Tong, Arunachalam Ilancheran, Yi Wan Lim, Siew Eng Lim, Natalie Ngoi, David Tan
Rok vydání: 2023
Předmět:
Zdroj: Gynecologic Oncology. 170:333
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2023.02.007
Databáze: OpenAIRE